Bonafi

About Us

At Bonafi, our mission is to keep people safe by helping businesses maximise their ability to maintain the integrity of the pharmaceutical supply chain. By talking to pharmaceutical manufacturers and wholesalers, we have learned that companies are looking for automation, reliability and a central location to manage their GDP bona fide qualifications.  

By transforming GDP compliance verification into Digital Business, we reduce the manual time taken to perform and make processes more robust, traceable and transparent. 

Bonafi is proud to be supported by Enterprise Ireland – in September 2019 we were awarded the Competitive Start Fund (CSF) investment. In addition, we are a New Frontiers Phase 2 company and a Dublin BIC client.  We are privileged to have advisors and mentors from Enterprise Ireland, Dublin BIC and many more who are experts in fields such as Pharma Quality Compliance and Pharmaceutical Quality Distribution, GDPR to mention a few.

Bonafi is based at the LINC Centre located right in the Blanchardstown Business & Technology Park only minutes from the M50 and the N3.

About the Founder

Katarina Antill is the Founder and Chief Executive Officer of Bonafi Limited. She founded Bonafi in 2018 as a part of her Executive MBA from Dublin City University (DCU).  

Katarina, originally from Sweden, has over 20 years of international corporate experience from biopharma and aviation  – two highly regulated industries. Most recently, prior to starting Bonafi, Katarina spent 10 years in various roles within the biopharma supply chain space where she saw a problem that needed solving. As she has a passion for using technology to improve business processes and the fact that she is no stranger to entrepreneurship, it was a natural step for her to design a solution and start Bonafi.  Besides her MBA degree from DCU, Katarina studied law in Sweden and holds a Masters of Law degree from Leiden University in the Netherlands.

Katarina is supported by a strong team of professionals with years of experience in their respective fields of technical product development, biopharma, business strategy, startup & entrepreneurship, and corporate finance.